Abstract:Aim: Microscopic bowel inflammation is present in up to 60% of all patients with spondyloarthritis (SpA) and appears to be associated with more severe joint disease and a higher risk of developing inflammatory bowel disease (IBD). This study aimed to determine the utility of fecal calprotectin (fCAL) in evaluating endoscopic and histological bowel inflammation in SpA patients.Methods: Ileocolonoscopies with biopsies and fCAL measurements were performed in 65 patients with SpA.
Results:In 47 (72.3%) patients, t… Show more
“…Dear editor, We read with great interest the article by Campos et al 1 which supported the evaluation of fecal calprotectin (fCAL) as a biomarker of microscopic bowel inflammation in spondyloarthritis (SpA) patients.…”
Section: O M M E N T Comment On Fecal Calprotectin As a Biomarker Of ...mentioning
“…Dear editor, We read with great interest the article by Campos et al 1 which supported the evaluation of fecal calprotectin (fCAL) as a biomarker of microscopic bowel inflammation in spondyloarthritis (SpA) patients.…”
Section: O M M E N T Comment On Fecal Calprotectin As a Biomarker Of ...mentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.